It was suggested that IFN-α and neopterin in cerebrospinal fluid (CSF) constitute promising biomarkers of neuropsychiatric SLE in a 5-year retrospective monocentric pediatric SLE cohort [117]. This evidence concerns the gene IFNA2 and systemic lupus erythematosus.